Vice President and Global Head of Neuromuscular Disease
Kathryn Wagner, MD PhD, is Vice President and Global Head of Neuromuscular Disease at F. Hoffmann La Roche. Formerly she was the Director of the Center for Genetic Muscle Disorders at the Kennedy Krieger Institute and Professor of Neurology and Neuroscience at the Johns Hopkins School of Medicine. She received her BS from Yale University and MD and PhD from the Johns Hopkins School of Medicine. Dr. Wagner's work focuses on muscle regeneration and therapeutic development for the muscular dystrophies. She is a scientific advisor for the FSH Society, Parent Project Muscular Dystrophy, and SOLID biosciences, chairperson of the TREAT-NMD Advisory Committee for Therapeutics and elected member of American Society for Clinical Investigation.